- Home
- SNES
SNES
SenesTech Inc.
as of 02-26-2026 3:08pm EST
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | PHOENIX |
| Market Cap: | 12.1M | IPO Year: | 2016 |
| Target Price: | N/A | AVG Volume (30 days): | 73.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.75 | EPS Growth: | 23.02 |
| 52 Week Low/High: | $1.30 - $5.99 | Next Earning Date: | N/A |
| Revenue: | $600,000 | Revenue Growth: | 132.56% |
| Revenue Growth (this year): | 41.52% | Revenue Growth (next year): | 77.28% |
| P/E Ratio: | -1.31 | Index: | N/A |
| Free Cash Flow: | -6117000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of SenesTech Inc. (SNES)
10% Owner
Avg Cost/Share
$2.40
Shares
34,613
Total Value
$83,140.43
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$2.29
Shares
10,481
Total Value
$24,001.49
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$2.29
Shares
40,807
Total Value
$93,492.92
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.89
Shares
15,390
Total Value
$29,105.57
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.72
Shares
7,956
Total Value
$13,688.30
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.73
Shares
8,000
Total Value
$13,873.60
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.77
Shares
2,884
Total Value
$5,106.12
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.82
Shares
5,685
Total Value
$10,373.42
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.98
Shares
42,739
Total Value
$84,418.07
Owned After
704,211
SEC Form 4
10% Owner
Avg Cost/Share
$1.87
Shares
5,399
Total Value
$10,105.85
Owned After
704,211
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 19, 2026 | Buy | $2.40 | 34,613 | $83,140.43 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 18, 2026 | Buy | $2.29 | 10,481 | $24,001.49 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 17, 2026 | Buy | $2.29 | 40,807 | $93,492.92 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 13, 2026 | Buy | $1.89 | 15,390 | $29,105.57 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 12, 2026 | Buy | $1.72 | 7,956 | $13,688.30 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 11, 2026 | Buy | $1.73 | 8,000 | $13,873.60 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 5, 2026 | Buy | $1.77 | 2,884 | $5,106.12 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 4, 2026 | Buy | $1.82 | 5,685 | $10,373.42 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Feb 2, 2026 | Buy | $1.98 | 42,739 | $84,418.07 | 704,211 | |
| GLENBROOK CAPITAL MANAGEMENT | SNES | 10% Owner | Jan 30, 2026 | Buy | $1.87 | 5,399 | $10,105.85 | 704,211 |
Compare SNES vs Leading Stocks
See how SNES stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SNES SenesTech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.